OncoFAP-68Ga - Philochem
Alternative Names: 68Ga-OncoFAP - Philochem; 68Ga-OncoFAP-DOTAGA - Philochem; OncoFAP-68GaLatest Information Update: 04 Dec 2023
At a glance
- Originator Philochem
- Class Antineoplastics; Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Solid tumours
Most Recent Events
- 04 Dec 2023 Preclinical trials in Solid tumours in Italy (IV) before December 2023 (Philogen pipeline, December 2023)
- 14 Apr 2023 Pharmacodynamics data from a preclinical trial in Solid tumours presented at the114th Annual Meeting of the American Association for Cancer Research (AACR-2023)
- 13 Mar 2023 Philogen plans a phase I trial for Solid tumours (Diagnosis) in Italy (NCT05784597)